PLUS THERAPEUTICS, INC. — Director's Dealing 2011

Jan 31, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-01-27

Reporting Person: Saad Mark E (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-27	Employee Stock Option	$5.57	A	50000	Acquired	2021-01-27	Common Stock (50000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	82500	Direct

Footnotes

F1: The Employee stock options vest 1/48th each month from the date of grant.